{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:43:24Z","timestamp":1776401004039,"version":"3.51.2"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/snuc.2001.26182","type":"journal-article","created":{"date-parts":[[2006,5,26]],"date-time":"2006-05-26T00:06:56Z","timestamp":1148602016000},"page":"278-285","source":"Crossref","is-referenced-by-count":16,"title":["Newer methods of labeling diagnostic agents with Tc-99m"],"prefix":"10.1053","volume":"31","author":[{"given":"Ronnie C.","family":"Mease","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/snuc.2001.26182_bib1","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/anie.199422581","article-title":"Technetium radiopharmaceuticals: Fundamentals, synthesis, structure, and development","volume":"33","author":"Schwochau","year":"1994","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1053\/snuc.2001.26182_bib2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/cr980435t","article-title":"Potential technetium small molecule radiopharmaceuticals","volume":"99","author":"Jurisson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1053\/snuc.2001.26182_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0969-8051(97)00066-8","article-title":"Technetium-99m-labeled receptorspecific small-molecule radiopharmaceuticals: Recent developments and encouraging results","volume":"24","author":"Hom","year":"1997","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/bc970058b","article-title":"99mTc labeling of highly potent small peptides","volume":"8","author":"Liu","year":"1997","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib5","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/cr980436l","article-title":"99mTc-labeled small peptides as diagnostic radiopharmaceuticals","volume":"99","author":"Liu","year":"1999","journal-title":"Chem Rev"},{"key":"10.1053\/snuc.2001.26182_bib6","first-page":"221","article-title":"Small peptides radiolabeled with 99mTc","volume":"40","author":"Lister-James","year":"1996","journal-title":"Q J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/bc00014a001","article-title":"Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium","volume":"3","author":"Griffiths","year":"1992","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0883-2897(91)90029-K","article-title":"Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies","volume":"18","author":"Srivastava","year":"1991","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1053\/snuc.2001.26182_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0020-1693(00)83233-8","article-title":"Lipophilic Tc complexes. VI. Neutral oxotechnetium(V) complexes with monothiol\/tridentate coordination","volume":"165","author":"Pietzsch","year":"1989","journal-title":"Inorg Chim Acta"},{"key":"10.1053\/snuc.2001.26182_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s002590050284","article-title":"Stability versus reactivity of \u201c3+1\u201d mixed-ligand technetium-99m complexes in vitro and in vivo","volume":"25","author":"Syhre","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib11","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1021\/jm981008a","article-title":"TROTEC-1: A new high-affinity ligand for labeling of the dopamine transporter","volume":"41","author":"Hoepping","year":"1998","journal-title":"J Med Chem"},{"key":"10.1053\/snuc.2001.26182_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0969-8051(96)00015-7","article-title":"Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: Structureaffinity considerations","volume":"23","author":"Johannsen","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib13","first-page":"316","article-title":"Structural modification of receptor-binding technetium-99m complexes in order to improve brain uptake","volume":"24","author":"Johannsen","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0969-8051(00)00083-4","article-title":"Radiochemical synthesis and tissue distribution of Tc-99m-labeled 7alpha-substituted estradiol complexes","volume":"27","author":"Skaddan","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib15","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1021\/jo990641g","article-title":"Synthesis and binding affinities of novel Re-containing 7a-substituted estradiol complexes: Models for breast cancer imaging agents","volume":"64","author":"Skaddan","year":"1999","journal-title":"J Org Chem"},{"key":"10.1053\/snuc.2001.26182_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0039-128X(98)00079-8","article-title":"Synthesis and binding affinities of new 17 alpha-substituted estradiol-rhenium \u201cn + 1\u201d mixed-ligand and thioether-carbonyl complexes","volume":"63","author":"Wust","year":"1998","journal-title":"Steroids"},{"key":"10.1053\/snuc.2001.26182_bib17","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0968-0896(99)00119-4","article-title":"Synthesis of novel progestin-rhenium conjugates as potential ligands for the progesterone receptor","volume":"7","author":"Wust","year":"1999","journal-title":"Bioorg Med Chem"},{"key":"10.1053\/snuc.2001.26182_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0969-8051(99)00107-9","article-title":"Assessment of the in vitro and in vivo properties of a 99mTc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein","volume":"27","author":"Bergmann","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib19","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1021\/ja980745t","article-title":"A novel organometallic aqua complex of technetium for the labeling of biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from from [99mTcO4]\u2212 in aqueous solution and its reaction with a bifunctional ligand","volume":"120","author":"Alberto","year":"1998","journal-title":"J Am Chem Soc"},{"key":"10.1053\/snuc.2001.26182_bib20","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1021\/ja990765a","article-title":"First application of fac-[99mTc(OH2)3(CO)3]+ in bioorganometallic chemistry: Design, structure, and in vitro affinity of a 5-HT1A receptor ligand labeled with 99MTc","volume":"121","author":"Alberto","year":"1999","journal-title":"J Am Chem Soc"},{"key":"10.1053\/snuc.2001.26182_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/bc990127h","article-title":"Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: A hint for the future functionalization of biomolecules","volume":"11","author":"Schibli","year":"2000","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0969-8051(99)00028-1","article-title":"In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc(CO)3]+-core","volume":"26","author":"Schibli","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/bc990162o","article-title":"Chemical and biological characterization of technetium(I) and rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)3 and Re(CO)3 moieties to biologically active molecules","volume":"11","author":"Pietzsch","year":"2000","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib24","first-page":"156P","article-title":"Preparation and biological evaluation of 99mTc(I)-carbonyl labeled octreotate conjugates","volume":"41","author":"Marmion","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0277-5387(97)00500-7","article-title":"Steps towards [(C5-Me5)TcO3] novel synthesis of [C5Me5)Tc(CO)3] from [{Tc(m3-OH)(CO)3}4] and oxidation of [(C5Me5)M(CO)3] (M = Tc, Re) with Br2","volume":"17","author":"Alberto","year":"1998","journal-title":"Polyhedron"},{"key":"10.1053\/snuc.2001.26182_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nbt0391-273","article-title":"The functional expression of antibody Fv fragments in Escherichia coli: Improved vectors and a generally applicable purification technique","volume":"9","author":"Skerra","year":"1991","journal-title":"Biotechnology (N Y)"},{"key":"10.1053\/snuc.2001.26182_bib27","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/12890","article-title":"Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex","volume":"17","author":"Waibel","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1053\/snuc.2001.26182_bib28","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1021\/ja982146s","article-title":"Boronic acids in the three-component synthesis of carbon-substituted cyclopentadienyl tricarbonyl rhenium complexes","volume":"120","author":"Minutolo","year":"1998","journal-title":"J Am Chem Soc"},{"key":"10.1053\/snuc.2001.26182_bib29","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1021\/ja980433q","article-title":"A convenient three-component synthesis of substituted cyclopentadienyl tricarbonyl rhenium complexes","volume":"120","author":"Minutolo","year":"1998","journal-title":"J Am Chem Soc"},{"key":"10.1053\/snuc.2001.26182_bib30","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1021\/om990128t","article-title":"Three-component synthesis of substituted h5-cyclopentadienyl tricarbonylrhenium complexes: Scope, limitations, and mechanistic interpretations","volume":"18","author":"Minutolo","year":"1998","journal-title":"Organometallics"},{"key":"10.1053\/snuc.2001.26182_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0969-8051(98)00060-2","article-title":"Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricar-bonyltechnetiumlabeled octreotide","volume":"26","author":"Spradau","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib32","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/om971018u","article-title":"Preparation of cyclopentadienyl tricarbonylrhenium complexes using a double ligand transfer reaction","volume":"17","author":"Spradau","year":"1998","journal-title":"Organometallics"},{"key":"10.1053\/snuc.2001.26182_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/bc980043t","article-title":"Protein and peptide labeling with (cyclopentadienyl)tricarbonyl rhenium and technetium","volume":"9","author":"Spradau","year":"1998","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib34","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/jm00033a010","article-title":"Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones","volume":"37","author":"Chi","year":"1994","journal-title":"J Med Chem"},{"key":"10.1053\/snuc.2001.26182_bib35","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1021\/ja00068a101","article-title":"Selective formation of heterodimeric bis-bidentate aminothiol oxometal complexes of rhenium(V)","volume":"115","author":"Chi","year":"1993","journal-title":"J Am Chem Soc"},{"key":"10.1053\/snuc.2001.26182_bib36","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1021\/jo951995k","article-title":"Heterodimeric bis(amino thiol) complexes of oxorhenium(V) that mimic the structure of steroid hormones. Synthesis and stereochemical issues","volume":"61","author":"Hom","year":"1996","journal-title":"J Org Chem"},{"key":"10.1053\/snuc.2001.26182_bib37","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1021\/jo970471c","article-title":"Synthesis of a tetradentate oxorhenium(V) complex mimic of a steroidal estrogen","volume":"62","author":"Hom","year":"1997","journal-title":"J Org Chem"},{"key":"10.1053\/snuc.2001.26182_bib38","first-page":"177","article-title":"Pharmacokinetics and renal handling of 99mTc-labeled peptides","volume":"41","author":"Trejtnar","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib39","first-page":"2022","article-title":"Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats","volume":"31","author":"Abrams","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/bc950069+","article-title":"Labeling a hydrazino nicotinamide-modified cyclic IIb\/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands","volume":"7","author":"Liu","year":"1996","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bc970002h","article-title":"New and versatile ternary ligand system for technetium radiopharmaceuticals: Water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamidemodified cyclic glycoprotein IIb\/IIIa receptor antagonist with 99mTc","volume":"8","author":"Edwards","year":"1997","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/bc990022e","article-title":"99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide","volume":"10","author":"Edwards","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/bc9800116","article-title":"A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands","volume":"9","author":"Liu","year":"1998","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib44","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/bc990049y","article-title":"RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging","volume":"10","author":"Edwards","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0969-8051(98)00118-8","article-title":"99m-Technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicity and stability on biodistribution","volume":"26","author":"Decristoforo","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib46","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/bc9900237","article-title":"Synthesis of stable hydrazones of a hydrazinonicotinyl-modified peptide for the preparation of 99mTc-labeled radiopharmaceuticals","volume":"10","author":"Harris","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib47","first-page":"1445","article-title":"Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent","volume":"32","author":"Kasina","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib48","first-page":"252","article-title":"Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma","volume":"37","author":"Blend","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00003072-199206000-00002","article-title":"Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard staging methods","volume":"17","author":"Balaban","year":"1992","journal-title":"Clin Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/bc970047i","article-title":"Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate)","volume":"9","author":"Kasina","year":"1998","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/bc9500958","article-title":"Labeling cyclic glycoprotein IIb\/IIIa receptor antagonists with 99mTc by the preformed chelate approach: Effects of chelators on properties of [99mTc]chelator-peptide conjugates","volume":"7","author":"Liu","year":"1996","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/bc980096a","article-title":"99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent","volume":"10","author":"Karra","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/bc970197t","article-title":"High-affinity no-carrieradded 99mTc-labeled chemotactic peptides for studies of inflammation in vivo","volume":"9","author":"Baidoo","year":"1998","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0969-8051(97)00028-0","article-title":"Validation and application of a solid phase chemistry method for preparation of high effective specific-activity technetium-99m radiopharmaceuticals","volume":"24","author":"Kao","year":"1997","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib55","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/bc990032f","article-title":"Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology","volume":"10","author":"Dunn-Dufault","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1053\/snuc.2001.26182_bib56","doi-asserted-by":"crossref","first-page":"11593","DOI":"10.1021\/ja9932941","article-title":"A convenient method of preparing high specific-activity technetium complexes using thiolcontaining chelators adsorbed on gold","volume":"121","author":"Pollak","year":"1999","journal-title":"J Am Chem Soc"},{"key":"10.1053\/snuc.2001.26182_bib57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0969-8051(00)00104-9","article-title":"Production of high purity 94mTc for positron emission tomography studies","volume":"27","author":"Qaim","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1053\/snuc.2001.26182_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02961596","article-title":"Technetium 94m-labeled methoxyisobutyl isonitrile: Dosimetry and resting cardiac imaging with positron emission tomography","volume":"1","author":"Stone","year":"1994","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/snuc.2001.26182_bib59","first-page":"1058","article-title":"Technetium-94m-teboroxime: Synthesis, dosimetry and initial PET imaging studies","volume":"34","author":"Nickles","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2001.26182_bib60","first-page":"S45","article-title":"Comparison of [94mTc]- and [99mTc]trodat-I as imaging agents for the dopamine transporter","volume":"42","author":"Szajek","year":"1999","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1053\/snuc.2001.26182_bib61","first-page":"3001s","article-title":"Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m","volume":"5","author":"Griffiths","year":"1999","journal-title":"Clin Cancer Res"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299801800076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299801800076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T09:53:17Z","timestamp":1547632397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299801800076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0001299801800076"],"URL":"https:\/\/doi.org\/10.1053\/snuc.2001.26182","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}